Alibaba Raises $10.2 Billion to Expand AI Infrastructure 
Anthropic IPO Could Challenge SpaceX’s Record $86 Billion Offering 
Amazon to Expand Drone Delivery to 500 U.S. Locations 
TikTok, DOJ Reach $400 Million Children’s Privacy Settlement 
Trump Buys SpaceX Shares After Record IPO 
Apple Cuts Over 200 Siri, Vision Pro Jobs in AI Shift 
Nvidia Eyes Perplexity Investment at $30 Billion Valuation 
Samsung Shares Tumble 8% as $79 Billion Return Plan Disappoints 
Bathla Group Hires Administrators as Australia Housing Slump Deepens 
Luxshare Shares Rise as First-Half Profit Jumps 18% 
California Seeks Paramount Divestitures in Warner Bros. Merger 
China EV Stocks Slide as Door Handle Recall Hits 4.3 Million Vehicles 
Nvidia AI Server Prices Set to Rise as Memory Costs Surge 
J.P. Morgan Upgrades Diploma, Lifts Price Target to 8,250p 
KPMG Australia Cuts 5% of Workforce Amid Scandal 
Unifor Reaches Tentative GM Deal for 4,600 Ontario Workers 
Ampol Profit Surges as Refining Margins Hit Record Highs 
Add as a preferred source on Google
BRANFORD, Conn., May 03, 2018 -- CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces that it will report financial results for the first quarter of 2018 on Thursday, May 10. Management will host a conference call to discuss these results and answer questions at 10:00 a.m. Eastern time that day.
Conference call dial-in information is as follows:
- U.S. callers: (866) 239-5859
- International callers: (702) 495-1913
Individuals interested in listening to the live conference call via the Internet may do so by logging on to the Company's website: www.casmed.com.
A telephone replay will be available from 1:00 p.m. Eastern time on May 10, 2018, through 11:59 p.m. Eastern time on May 23, 2018. Replay dial-in information is as follows:
- U.S. callers: (855) 859-2056
- International callers: (404) 537-3406
- Conference ID number (U.S. and international): 4358709
- The replay will also be available at www.casmed.com.
About CASMED® – Monitoring What's Vital
CASMED FORE-SIGHT® Cerebral Oximeters provide a highly accurate, non-invasive measurement of tissue oxygenation in the brain. Direct monitoring of tissue oxygenation can provide a superior and powerful tool to alert clinicians to otherwise unrecognized and dangerously low levels of oxygen in the brain and empower them to improve patient care. For further information regarding CASMED, visit the Company's website at www.casmed.com.
Company Contacts
CAS Medical Systems, Inc.
Jeffery A. Baird
Chief Financial Officer
(203) 315-6303
[email protected]
Investors
LHA Investor Relations
Bruce Voss / Jody Cain
(310) 691-7100
[email protected]
[email protected]
@LHA_IR_PR
